Sugammadex Injection, Solution
Product Images NDC 55579-892

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 55579-892). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solupharm Pharmazeutische Erzeugnisse Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 01)

Chemical structure diagram of sugammadex sodium, showing its complex cyclic molecular arrangement with multiple sugar-like ring structures and sodium carboxylate groups.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 02)

Chemical structure diagram of sugammadex sodium, showing its cyclic molecular configuration with multiple sodium carboxylate groups and sulfur atoms.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 03)

A cumulative recovery rate chart comparing sugammadex 2 mg/kg and neostigmine 0.05 mg/kg with rocuronium plus. The x-axis represents time to recovery in minutes up to 120, and the y-axis shows cumulative recovery rate from 0 to 1. Sugammadex shows a faster recovery median time of 1.4 minutes compared to 21.5 minutes for neostigmine, based on 48 observations each.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 04)

A cumulative recovery rate chart comparing sugammadex 2 mg/kg and neostigmine 0.05 mg/kg over time in minutes. The x-axis shows time to recovery (minutes), and the y-axis shows cumulative recovery rate from 0 to 1. Sugammadex shows a faster recovery time than neostigmine, with median recovery times noted (2.1 minutes for sugammadex and 29.0 minutes for neostigmine). The chart includes censored observations and quartile estimates.*

FDA Label Image

Label (Label)

Packaging label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) intravenous solution. The label indicates 10 single-dose 2 mL vials per package, manufactured by Somerset Therapeutics LLC. The label includes dosage information noting each mL contains 100 mg sugammadex, and the product is for intravenous use only. Storage and handling instructions are also partially visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.